patients with advanced hepatocellular carcinoma: A real life data of

Autor: Hacioglu, MB, Kostek, O, Karabulut, S, Tastekin, D, Goksu, SS, Alandag, C, Akagunduz, B, Bilgetekin, I, Caner, B, Sahin, AB, Yildiz, B, Kose, F, Kaplan, MA, Gulmez, A, Dogan, E, Guven, DC, Gurbuz, M, Ergun, Y, Karaagac, M, Demiray, AG, Turker, S, Sakalar, T, Ozkul, O, Telli, TA, Sahin, S, Kilickap, S, Bilici, A, Erdogan, B, Cicin, I

Purpose: After failure of the first-line sorafenib treatment in advanced or metastatic stage hepatocellular carcinoma (HCC), regorafenib is one of the newly-approved targeted agents. We aimed to evaluate the efficacy of regorafenib in patients with a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::2329afb7eb9d0c2c36789589ee99600e

Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib

Autor: Nazım Can Demircan, K İşsever, Irfan Cicin, Ahmet Kucukarda, S Solak, Ali Gökyer, Bulent Erdogan, B S Sunal, Osman Kostek, Sernaz Uzunoglu, Muhammet Bekir Hacioglu

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 21(11)

BackgroundSarcopenia is related to poor prognosis and drug toxicities in solid tumors. The aim of our study is to investigate the predisposition of patients with metastatic colorectal carcinoma who started regorafenib treatment to sarcopenia and prol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108fca444637aa60ad642c6d1d5b98ca
https://pubmed.ncbi.nlm.nih.gov/30868388

Major and minor salivary gland cancers: A multicenter retrospective study.

Autor: Hacioglu MB; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Erdogan B; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Bardakcı M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Algın E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Gulbagcı B; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Hacibekiroglu I; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Hamdard J; Department of Medical Oncology, Faculty of Medicine, Medipol University, İstanbul, Turkey., Olmez OF; Department of Medical Oncology, Faculty of Medicine, Medipol University, İstanbul, Turkey., Akkus H; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey., Oksuzoglu B; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey., Goksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Dae SA; Department of Medical Oncology, Faculty of Adana Medicine, Baskent University, Adana, Turkey., Sumbul AT; Department of Medical Oncology, Faculty of Adana Medicine, Baskent University, Adana, Turkey., Ugraklı M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Karaagac M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Sahin E; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Cabuk D; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Ozer O; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey., Yavuzsen T; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey., Arıkan R; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Köstek O; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Atcı MM; Department of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey., Sakin A; Department of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey., Deligonul A; Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey., Bayır D; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey., Dincer M; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey., Unsal O; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey., Yazıcı O; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey., Zeynelgil E; Department of Medical Oncology, Diskapi Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey., Gulmez A; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey., Harputluoglu H; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey., Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazit University, Ankara, Turkey., Sendur MAN; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazit University, Ankara, Turkey., Aytekin A; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey., Akagunduz B; Department of Medical Oncology, Mengucek Gazi Education and Research Hospital, Erzincan Binali Yıldırım University, Erzincan, Turkey., Oner I; Department of Medical Oncology, Konya City Hospital, Konya, Turkey., Er O; Department of Medical Oncology, Maslak Hospital, Acıbadem MAA University, Istanbul, Turkey., Oztosun B; Department of Medical Oncology, Goztepe Education and Research Hospital, Medeniyet University, Istanbul, Turkey., Gumus M; Department of Medical Oncology, Goztepe Education and Research Hospital, Medeniyet University, Istanbul, Turkey., Selçukbiricik F; Department of Medical Oncology, Koc University Hospital, Istanbul, Turkey., Aykan MB; Department of Medical Oncology, Ankara Gulhane Education and Research Hospital, Ankara, Turkey., Karadurmus N; Department of Medical Oncology, Ankara Gulhane Education and Research Hospital, Ankara, Turkey., Degerli E; Department of Medical Oncology, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey., Demirci NS; Department of Medical Oncology, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey., Turkmen E; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey., Şakalar T; Department of Medical Oncology, Kahramanmaras Necip Fazıl City Hospital, Kahramanmaras, Turkey., Secmeler S; Department of Medical Oncology, Sanlıurfa Mehmet Akif İnan Education and Research Hospital, Şanlıurfa, Turkey., Tanrıverdi O; Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla, Turkey., Alkan A; Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla, Turkey., Kemal Y; Department of Medical Oncology, Faculty of Medicine, Altınbas University, Samsun, Turkey., Cil I; Department of Medical Oncology, Istanbul Umraniye Education and Research Hospital, Istanbul, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul Bilim University, Istanbul, Turkey., Iriagaç Y; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namık Kemal University, Tekirdag, Turkey., Alan O; Department of Medical Oncology, Tekirdag City Hospital, Tekirdag, Turkey., Balli S; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Urun Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Ozcan E; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.

Publikováno v: Head & neck [Head Neck] 2023 Jul; Vol. 45 (7), pp. 1643-1653. Date of Electronic Publication: 2023 Apr 21.

The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas.

Autor: Korkmaz U; Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey., Hacioglu MB; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Kostek O; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Sut N; Department of Statistics, Faculty of Medicine, Trakya University, Edirne, Turkey., Kodaz H; Department of Medical Oncology, Acıbadem Eskişehir Hospital, Eskişehir, Turkey., Erdogan B; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Ustun F; Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey., Saynak M; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Tastekin E; Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey., Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Durmus-Altun G; Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.

Publikováno v: Polish journal of radiology [Pol J Radiol] 2020 May 15; Vol. 85, pp. e254-e260. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).

Renal cell carcinoma presenting with heart metastasis without inferior vena caval and right atrial involvement.

Autor: Sahin S; Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey., Karatas F; Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey., Hacioglu MB; Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey., Aytekin A; Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey., Cilbir E; Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey., Conkbayir I; Department of Radiology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2018 Jan-Mar; Vol. 14 (2), pp. 457-458.